Gates alumna published in Nature

  • December 3, 2010

Dr Tiffany Bogich has co-authored a paper on zoonotic disease.

A Gates alumna has co-authored a paper in Nature this week on her research into where the next infectious disease to be passed from animals to humans will come from.

The paper, Impacts of biodiversity and the emergence and transmission of infectious diseases, coauthored by Dr Tiffany Bogich [2006], was published on 2 December. It reviews the evidence for whether declines in biodiversity affect the transmission of infectious diseases. It concludes that “preserving intact ecosystems and their biodiversity should generally reduce the prevalence of infectious diseases”.

Dr Bogich’s collaboration on the paper came through her work with the EcoHealth Alliance, a non-governmental organisation based in New York. The organisation is in the second year of a five-year funded USAID project which is trying to develop and improve global-scale risk models to better predict where the next zoonotic disease will come from. It is also working on the ground to improve capacity in developing countries where this risk is thought to be greatest. Surveillance for new pathogens is currently being conducted in approximately 24 countries, with a focus on potential diseases coming from bats, rodents and primates.

The modeling work uses the same global-scale approach as her PhD work, which looked at how to best predict animal extinction based on global changes in land use.

Case study

 

Latest News

2026 US Scholars announced

Twenty-six of the most academically brilliant social leaders in the US have been selected to be part of the 2026 class of Gates Cambridge Scholars at the University of Cambridge. […]

Advocating for gender minorities worldwide

Muaz Chaudhry is proud to have carved his own path, defying social expectations and norms to do impactful research in the field of gender economics and to lead an NGO, […]

Scholar contributes to international AI safety report

A Gates Cambridge Scholar is a contributor to the new International AI Safety Report 2026, the most comprehensive evidence-based assessment of AI capabilities, emerging risks and safety measures to date. […]

Top health innovation role for Gates Cambridge Scholar

Gates Cambridge Scholar Lina Scroggins has been appointed chief product officer at leading US health firm Mercy. Lina [2005], who did her MPhil in Biological Science, has been working for […]